This lecture will review new research efforts underway to better understand brain structure and function in mood disorders using a variety of methods (e.g., neuroimaging, genetics, electrophysiology) in the context of treatment with rapid acting antidepressant agents. These next generation studies will likely focus on more precise diagnoses and a personalized medicine paradigm in order to develop better treatments for those who need them most.
Carlos A. Zarate, M.D. is chief of the Section on Neurobiology and Treatment of Mood and Anxiety Disorders, Division Intramural Research Program, at the National Institute of Mental Health, Clinical Professor of Psychiatry and Behavioral Sciences, at the George Washington University and Professor of Psychiatry and Behavioral Sciences, at the Howard Medical School.
Dr Zarate is also a scientific advisory board member with International Bipolar Foundation.